tm logo
Trademark Search
EMERALD

View On IC.GC.CA

EMERALD
ABANDONED SECTION 36

on 21 Jun 2022

Last Applicant/ Owned by

EMERALD HEALTH SCIENCES INC.

410-221 West EsplanadeNorth Vancouver

BRITISH COLUMBIA

CA

V7M3J3

Serial Number

1729333 filed on 21st May 2015

Correspondent Address

101 - 1001 West Broadway, Suite 380Vancouver

BRITISH COLUMBIA

CA

V6H4E4

EMERALD

Trademark usage description

protein powders for meal replacement; botanical, herbal, nutraceutical, dietary and nutritional supplements for general health and well-being; botanic Read More

Classification Information

Class [005]
Protein powders for meal replacement; Botanical, herbal, nutraceutical, dietary and nutritional supplements for general health and well-being; botanical, herbal, nutraceutical, dietary and nutritional preparations and botanical, herbal, nutraceutical, dietary and nutritional substances containing plant extracts and plant-derived nutrients to reduce stress and fatigue, increase appetite, reduce anxiety, relax tension, mood enhancement and provide an improved sense of well-being; Pharmaceutical and nutraceutical preparations and pharmaceutical and nutraceutical substances containing plant extracts and plant derived ingredients for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis,Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; medicinal herbs, medicinal oils, medicinal infusions for treating metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; appetite suppressants for medical purpose.

Classification kind code

11

Class [035]
Retail sale and sale of dietary and nutritional supplements, pharmaceutical preparations accessible online and by telephone, facsimile and mail order; online sale services in the field of dietary and nutritional supplements, pharmaceutical preparations; Distributorships in the field of dietary and nutritional supplements, pharmaceutical preparations.

Classification kind code

11

Mark Details

Serial Number

1729333

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 87
on 01st Dec 2017		Rep for Service Changed
Submitted for opposition 12
on 30th Aug 2017		Extension of Time
Submitted for opposition 12
on 15th Feb 2017		Extension of Time
Submitted for opposition 15
on 10th Aug 2016		Correspondence Created
Submitted for opposition 22
on 23rd Nov 2015		Search Recorded
Submitted for opposition 20
on 23rd Nov 2015		Examiner's First Report
Submitted for opposition 135
on 07th Jul 2015		Amendment to Application
Submitted for opposition 31
on 29th May 2015		Formalized
Submitted for opposition 1
on 22nd May 2015		Created
Submitted for opposition 30
on 21st May 2015		Filed